Search research articles
Contact Us
Filters
Showing results (111-120 of 140) with videos related to
Page
of 14
Sort By:
Genome Medicine
|
October 27, 2021
Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in App<sup>NL-G-F</sup>, App<sup>NL-F</sup>, and 3xTg-AD mouse models
Eduardo Pauls, Sergi Bayod, Lídia Mateo, et al.
Nature Communications
|
June 25, 2021
Bioactivity descriptors for uncharacterized chemical compounds
Martino Bertoni, Miquel Duran-Frigola, Pau Badia-I-Mompel, et al.
JHEP Reports : Innovation in Hepatology
|
May 11, 2022
Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
Isabel Graupera, Laura Isus, Mar Coll, et al.
Nucleic Acids Research
|
March 12, 2025
Systematic study of hybrid triplex topology and stability suggests a general triplex-mediated regulatory mechanism
Vito Genna, Guillem Portella, Alba Sala, et al.
Science (New York, N.Y.)
|
May 7, 2021
Environmental robustness of the global yeast genetic interaction network
Michael Costanzo, Jing Hou, Vincent Messier, et al.
Journal of Proteome Research
|
December 30, 2014
Yeast mitochondrial protein-protein interactions reveal diverse complexes and disease-relevant functional relationships
Ke Jin, Gabriel Musso, James Vlasblom, et al.
Nature Biotechnology
|
February 25, 2014
The binary protein-protein interaction landscape of Escherichia coli
Seesandra V Rajagopala, Patricia Sikorski, Ashwani Kumar, et al.
Cell Reports
|
January 18, 2016
Conditional Epistatic Interaction Maps Reveal Global Functional Rewiring of Genome Integrity Pathways in Escherichia coli
Ashwani Kumar, Natalia Beloglazova, Cedoljub Bundalovic-Torma, et al.
Cell Systems
|
March 3, 2026
The modifiers that cause changes in gene essentiality
Amandine Batté, Núria Bosch-Guiteras, Carles Pons, et al.
Journal of Chemical Information and Modeling
|
July 17, 2020
Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs
Miquel Duran-Frigola, Martino Bertoni, Roi Blanco, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 140) with videos related to
Sort By:
Page
of 14
Genome Medicine
|
October 27, 2021
Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in App<sup>NL-G-F</sup>, App<sup>NL-F</sup>, and 3xTg-AD mouse models
Eduardo Pauls, Sergi Bayod, Lídia Mateo, et al.
Nature Communications
|
June 25, 2021
Bioactivity descriptors for uncharacterized chemical compounds
Martino Bertoni, Miquel Duran-Frigola, Pau Badia-I-Mompel, et al.
JHEP Reports : Innovation in Hepatology
|
May 11, 2022
Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
Isabel Graupera, Laura Isus, Mar Coll, et al.
Nucleic Acids Research
|
March 12, 2025
Systematic study of hybrid triplex topology and stability suggests a general triplex-mediated regulatory mechanism
Vito Genna, Guillem Portella, Alba Sala, et al.
Science (New York, N.Y.)
|
May 7, 2021
Environmental robustness of the global yeast genetic interaction network
Michael Costanzo, Jing Hou, Vincent Messier, et al.
Journal of Proteome Research
|
December 30, 2014
Yeast mitochondrial protein-protein interactions reveal diverse complexes and disease-relevant functional relationships
Ke Jin, Gabriel Musso, James Vlasblom, et al.
Nature Biotechnology
|
February 25, 2014
The binary protein-protein interaction landscape of Escherichia coli
Seesandra V Rajagopala, Patricia Sikorski, Ashwani Kumar, et al.
Cell Reports
|
January 18, 2016
Conditional Epistatic Interaction Maps Reveal Global Functional Rewiring of Genome Integrity Pathways in Escherichia coli
Ashwani Kumar, Natalia Beloglazova, Cedoljub Bundalovic-Torma, et al.
Cell Systems
|
March 3, 2026
The modifiers that cause changes in gene essentiality
Amandine Batté, Núria Bosch-Guiteras, Carles Pons, et al.
Journal of Chemical Information and Modeling
|
July 17, 2020
Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs
Miquel Duran-Frigola, Martino Bertoni, Roi Blanco, et al.
Page
of 14